Tilray Brands (TLRY) Shares Outstanding (Weighted Average) (2017 - 2025)
Tilray Brands (TLRY) reported Shares Outstanding (Weighted Average) of $1.1 billion for Q3 2025, up 16976.37% on a YoY basis from N/an in Q3 2024, and up 170663.71% quarter-over-quarter from $620900.0 in Q2 2025.
Tilray Brands (TLRY) Shares Outstanding (Weighted Average) (2017 - 2025) Analysis & Trends
Tilray Brands has reported Shares Outstanding (Weighted Average) for 9 years, with the latest figure at $1.1 billion in Q3 2025.
- For the quarter ending Q3 2025, Shares Outstanding (Weighted Average) rose 16976.37% year-over-year to $1.1 billion; the trailing twelve-month figure through Aug 2025 stood at $1.1 billion (up 16976.37% YoY), and the FY2025 full-year result was $890.3 million, up 14239.28% from the prior year.
- Shares Outstanding (Weighted Average) for Q3 2025 stood at $1.1 billion, up from $620900.0 in the prior quarter.
- The five-year high for Shares Outstanding (Weighted Average) was $1.1 billion in Q3 2025, with the low at $620900.0 in Q2 2025.
- Historically, Shares Outstanding (Weighted Average) has averaged $393.8 million across 5 years, with a median of $454.8 million in 2021.
- Annual changes were most pronounced in 2024 — Shares Outstanding (Weighted Average) slumped 99.1% — and 2025, when it soared 16976.37%.
- Tilray Brands' Shares Outstanding (Weighted Average) stood at $454.8 million in 2021, then increased by 29.53% to $589.1 million in 2022, then increased by 24.05% to $730.8 million in 2023, then slumped by 88.16% to $86.5 million in 2024, then jumped by 1125.78% to $1.1 billion in 2025.
- The last three Shares Outstanding (Weighted Average) figures came in at $1.1 billion (Q3 2025), $620900.0 (Q2 2025), and $90.8 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 64.74 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | Tilray Brands | - | - | 54.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2025 | 1.06 Bn |
| May 31, 2025 | 620,900.00 |
| Feb 28, 2025 | 90.83 Mn |
| Nov 30, 2024 | 86.50 Mn |
| Aug 31, 2024 | 6.21 Mn |
| May 31, 2024 | 6.21 Mn |
| Feb 29, 2024 | 6.21 Mn |
| Nov 30, 2023 | 730.77 Mn |
| Aug 31, 2023 | 691.19 Mn |
| May 31, 2023 | 617.98 Mn |
| Feb 28, 2023 | 615.53 Mn |
| Nov 30, 2022 | 589.11 Mn |
| Aug 31, 2022 | 575.30 Mn |
| May 31, 2022 | 481.22 Mn |
| Feb 28, 2022 | 485.67 Mn |
| Nov 30, 2021 | 454.80 Mn |
| Aug 31, 2021 | 449.40 Mn |
| May 31, 2021 | 269.55 Mn |
| Feb 28, 2021 | 265.40 Mn |
| Nov 30, 2020 | 242.21 Mn |